(Circulation. 1999;99:53-59.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Superoxide Production, Risk Factors, and Endothelium-Dependent Relaxations in Human Internal Mammary Arteries
From the Department of Anesthesiology (C.H., T.M., K.Y., F.S., J.H.L.) and Department of Medicine, Divisions of Cardiology (S.K., D.G.H.) and Hematology and Oncology (J.N.W.), Emory University Hospital, Atlanta, Ga, and Department of Anesthesiology, University of Alabama, Birmingham, Ala (M.M.T.).
Correspondence to Jerrold H. Levy, MD, Department of Anesthesiology, Emory University Hospital, 1364 Clifton Rd NE, Atlanta, GA 30322. E-mail jerrold_levy{at}emory.org
Background—In a variety of disease states, endothelium-dependent vasodilation is abnormal. Reduced nitric oxide (NO) production, increased destruction of NO by superoxide, diminished cellular levels of L-arginine or tetrahydrobiopterin, and alterations in membrane signaling have been implicated. We examined these potential mechanisms in human vessels.
Methods and Results—Relaxations to acetylcholine, the calcium ionophore A23187, and nitroglycerin, as well as superoxide production and NO synthase expression, were examined in vascular segments from patients with identified cardiovascular risk factors. Endothelium-dependent relaxations were also studied after incubation with L-arginine, L-sepiapterin, and liposome-entrapped superoxide dismutase (SOD) and after organoid culture with cis-vaccenic acid. Relaxations to acetylcholine and to a lesser extent the calcium ionophore A23187 were highly variable and correlated with the number of risk factors present among the subjects studied. Treatment of vessels with L-arginine, L-sepiapterin, liposome-entrapped SOD, or cis-vaccenic acid did not augment endothelium-dependent relaxations. Hypercholesterolemia was the only risk factor associated with high levels of superoxide; however, there was no correlation between superoxide production and the response to either endothelium-dependent vasodilator used.
Conclusions—In human internal mammary arteries, depressed endothelium-dependent relaxations could not be attributed to increases in vascular superoxide production, deficiencies in either L-arginine or tetrahydrobiopterin, or reduced membrane fluidity. Variability in signaling mechanisms may contribute to the differences in responses to acetylcholine and the calcium ionophore A23187.
Key Words: arteries • atherosclerosis • endothelium • nitric oxide • risk factors
This article has been cited by other articles:
 |
|
 |
|
  A. U. Momin, N. Melikian, A. M. Shah, D. J. Grieve, S. B. Wheatcroft, L. John, A. El Gamel, J. B. Desai, T. Nelson, C. Driver, et al. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance Eur. Heart J., October 1, 2006; 27(19): 2294 - 2299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Al-Benna, C. A. Hamilton, J. D. McClure, P. N. Rogers, G. A. Berg, I. Ford, C. Delles, and A. F. Dominiczak Low-Density Lipoprotein Cholesterol Determines Oxidative Stress and Endothelial Dysfunction in Saphenous Veins From Patients With Coronary Artery Disease Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 218 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ergul, J. S. Johansen, C. Stromhaug, A. K. Harris, J. Hutchinson, A. Tawfik, A. Rahimi, E. Rhim, B. Wells, R. W. Caldwell, et al. Vascular Dysfunction of Venous Bypass Conduits Is Mediated by Reactive Oxygen Species in Diabetes: Role of Endothelin-1 J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 70 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Guzik, J. Sadowski, B. Kapelak, A. Jopek, P. Rudzinski, R. Pillai, R. Korbut, and K. M. Channon Systemic Regulation of Vascular NAD(P)H Oxidase Activity and Nox Isoform Expression in Human Arteries and Veins Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1614 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hambrecht, V. Adams, S. Erbs, A. Linke, N. Krankel, Y. Shu, Y. Baither, S. Gielen, H. Thiele, J.F. Gummert, et al. Regular Physical Activity Improves Endothelial Function in Patients With Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase Circulation, July 1, 2003; 107(25): 3152 - 3158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Blau, B. Thony, J. Vasquez-Vivar, and S. Rajagopalan Possible Impact of Tetrahydrobiopterin and Sepiapterin on Endothelial Dysfunction * In Response: Arterioscler Thromb Vasc Biol, May 1, 2003; 23(5): 913 - 915. [Full Text] [PDF]
|
|
|
|
 |
|
 R. De Caterina and C. Manes Inflammation in early atherogenesis: impact of ACE inhibition Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A15 - A24. [Abstract] [PDF]
|
|
|
|
|
|
J. Vasquez-Vivar, D. Duquaine, J. Whitsett, B. Kalyanaraman, and S. Rajagopalan Altered Tetrahydrobiopterin Metabolism in Atherosclerosis: Implications for Use of Oxidized Tetrahydrobiopterin Analogues and Thiol Antioxidants Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1655 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yokoyama, M. Tajima, H. Yoshida, M. Nakayama, G. Tokutome, H. Sakagami, and T. Hosoya Plasma pteridine concentrations in patients with chronic renal failure Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1032 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. N. Diep, M. El Mabrouk, J. S. Cohn, D. Endemann, F. Amiri, A. Virdis, M. F. Neves, and E. L. Schiffrin Structure, Endothelial Function, Cell Growth, and Inflammation in Blood Vessels of Angiotensin II-Infused Rats: Role of Peroxisome Proliferator-Activated Receptor-{gamma} Circulation, May 14, 2002; 105(19): 2296 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, and T. Munzel Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease Circulation, November 27, 2001; 104(22): 2673 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pompilio, G. Rossoni, F. Alamanni, P. Tartara, I. Barajon, C. Rumio, B. Manfredi, and P. Biglioli Comparison of endothelium-dependent vasoactivity of internal mammary arteries from hypertensive, hypercholesterolemic, and diabetic patients Ann. Thorac. Surg., October 1, 2001; 72(4): 1290 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Barton and B. Glodny Endothelin receptor blockade and nitric oxide bioactivity: [Cardiovascular Research 2001;49:146-151] Cardiovasc Res, October 1, 2001; 52(1): 161 - 163. [Full Text] [PDF]
|
|
|
|
 |
|
 C. BERRY, N. ANDERSON, A. J B KIRK, A. F DOMINICZAK, and J. J V MCMURRAY Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease Heart, August 1, 2001; 86(2): 217 - 220. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Y. Chirkov, A. S. Holmes, S. R. Willoughby, S. Stewart, R. D. Wuttke, P. R. Sage, and J. D. Horowitz Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1851 - 1857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Hamilton, M. J. Brosnan, M. McIntyre, D. Graham, and A. F. Dominiczak Superoxide Excess in Hypertension and Aging : A Common Cause of Endothelial Dysfunction Hypertension, February 1, 2001; 37(2): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Verma, F. Lovren, A. S Dumont, K. J Mather, A. Maitland, T. M Kieser, W. Kidd, J. H McNeill, D. J Stewart, C. R Triggle, et al. Endothelin receptor blockade improves endothelial function in human internal mammary arteries Cardiovasc Res, January 1, 2001; 49(1): 146 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Verma, F. Lovren, A. S. Dumont, K. J. Mather, A. Maitland, T. M. Kieser, C. R. Triggle, and T. J. Anderson Tetrahydrobiopterin improves endothelial function in human saphenous veins J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 668 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ruschitzka, U. Moehrlen, T. Quaschning, M. Lachat, G. Noll, S. Shaw, Z. Yang, D. Teupser, T. Subkowski, M. I. Turina, et al. Tissue Endothelin-Converting Enzyme Activity Correlates With Cardiovascular Risk Factors in Coronary Artery Disease Circulation, September 5, 2000; 102(10): 1086 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Guzik, N. E. J. West, E. Black, D. McDonald, C. Ratnatunga, R. Pillai, and K. M. Channon Vascular Superoxide Production by NAD(P)H Oxidase : Association With Endothelial Dysfunction and Clinical Risk Factors Circ. Res., May 12, 2000; 86 (9): e85 - e90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Berry, C. A. Hamilton, M. J. Brosnan, F. G. Magill, G. A. Berg, J. J. V. McMurray, and A. F. Dominiczak Investigation Into the Sources of Superoxide in Human Blood Vessels : Angiotensin II Increases Superoxide Production in Human Internal Mammary Arteries Circulation, May 9, 2000; 101(18): 2206 - 2212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin, J. B. Park, H. D. Intengan, and R. M. Touyz Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan Circulation, April 11, 2000; 101(14): 1653 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Guzik, S. Mussa, D. Gastaldi, J. Sadowski, C. Ratnatunga, R. Pillai, and K. M. Channon Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase Circulation, April 9, 2002; 105(14): 1656 - 1662. [Abstract] [Full Text] [PDF]
|
|